BRIEF published on 07/25/2024 at 22:03, 1 year 6 months ago Vitruvia Medical AG: Half-Year Results as of June 30, 2024 Financial Performance Half-year Results 2024 Forecast Sales Targets Vitruvia Medical AG
PRESS RELEASE published on 07/25/2024 at 21:58, 1 year 6 months ago EQS-Adhoc: Vitruvia Medical AG: Half yearly results as per June 30th, 2024 Vitruvia Medical AG reports half-year results in line with expectations for the first half of 2024, confirming full-year forecast. Positive outlook with expected sales around EUR 2.0 million Sales Forecast Earnings Half-year Results Vitruvia Medical AG
BRIEF published on 05/01/2024 at 08:41, 1 year 9 months ago Vitruvia Medical AG annonce de meilleurs résultats financiers de fin d'année pour 2023 Résultats Financiers Perspectives 2024 Hausse Des Revenus Vitruvia Médical SA Amélioration De L'EBITA
BRIEF published on 05/01/2024 at 08:41, 1 year 9 months ago Vitruvia Medical AG Announces Improved Year-End Financial Results for 2023 Financial Results Revenue Growth 2024 Outlook Vitruvia Medical AG EBITA Improvement
PRESS RELEASE published on 05/01/2024 at 08:36, 1 year 9 months ago EQS-Adhoc: Vitruvia Medical AG: Year End results as of December 31, 2023 Vitruvia Medical AG reports Year End results for 2023 with revenue and earnings growth. Financial performance overview and outlook for LT technologies for 2024 Revenue Growth Financial Performance Vitruvia Medical AG Year End Results LT Technologies
PRESS RELEASE published on 09/29/2023 at 13:15, 2 years 4 months ago Vitruvia Medical AG: Consolidated interim results as per June 30th,2023
PRESS RELEASE published on 09/29/2023 at 12:15, 2 years 4 months ago EQS-Adhoc: Vitruvia Medical AG: Consolidated interim results as per June 30th,2023
PRESS RELEASE published on 07/28/2023 at 08:17, 2 years 6 months ago Vitruvia Medical AG: Shareholders approved all proposals at the Annual General Meeting of Shareholders
PRESS RELEASE published on 06/25/2023 at 09:59, 2 years 7 months ago EQS-Adhoc: Vitruvia Medical AG: Annual results as of 31.12.2022 and outlook 2023
PRESS RELEASE published on 03/27/2023 at 11:34, 2 years 10 months ago EQS-Adhoc: Vitruvia Medical AG: auhtorised capital increase
Published on 02/20/2026 at 20:15, 17 minutes ago Lithium South Announces Results of its Annual and Special Meeting of Securityholders
Published on 02/20/2026 at 20:15, 17 minutes ago Verdera Energy Announces Closing of Qualifying Transaction
Published on 02/20/2026 at 18:30, 2 hours 2 minutes ago Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 4 hours 47 minutes ago Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 6 hours 2 minutes ago Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 18:36, 1 hour 55 minutes ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:00, 2 hours 32 minutes ago Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 2 hours 32 minutes ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 19:29, 1 hour 2 minutes ago SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 19:29, 1 hour 2 minutes ago SFPI GROUP: bilan du contrat de liquidité S2 S025
Published on 02/20/2026 at 18:00, 2 hours 32 minutes ago TERACT - Résiliation du contrat de liquidité
